Male sex, n (%) | 180 (60.6) |
Ever smoking, n (%) | 162 (54.5) |
Age (years), median, (q1-q3) | 66 (59–74) |
Immunosuppressive conditions, n (%) | |
Hematological malignancies | 107 (36.0) |
Non-Hodgkin’s lymphoma | 55 (18.5) |
Chronic leukemia | 17 (5.7) |
Plasma cell disease | 15 (5.1) |
Acute leukemia | 11 (3.7) |
Hodgkin’s lymphoma | 9 (3.0) |
Solid tumors | 75 (25.3) |
Lung including pleural membranes | 27 (9.1) |
Breast | 14 (4.7) |
Genitourinary tract | 14 (4.7) |
Gastrointestinal tract | 9 (3.0) |
Other primary tumora | 11 (3.7) |
Immunological disorders | 46 (15.5) |
Rheumatoid arthritis | 16 (5.4) |
Connective tissue disorders and vasculitidies | 15 (5.1) |
Miscellaneousb disorders | 15 (5.1) |
Solid organ transplantations | 37 (12.5) |
Kidney | 31 (10.4) |
Heart, lung | 6 (2.0) |
Chronic lung diseases | 18 (6.1) |
Interstitial lung disease or sarcoidosis | 11 (3.7) |
Chronic obstructive pulmonary disease | 7 (2.4) |
HIV-infection | 7 (2.4) |
Otherc | 7 (2.4) |
Comorbid conditions, n (%) | |
Hypertension | 92 (31.0) |
Cardiovascular disease | 83 (27.9) |
Chronic pulmonary disease | 52 (17.5) |
Diabetes mellitus type 1 or 2 | 44 (14.8) |
Solid tumor | 30 (10.1) |
Chronic kidney disease | 38 (12.8) |
Congestive heart failure | 18 (6.1) |
Rheumatic disease | 12 (4.0) |
Hematological malignancyd | 13 (4.4) |
Chronic liver disease | 4 (1.4) |
Charlson comorbidity index, n (%) | |
< 4 | 47 (15.8) |
4–6 | 132 (44.4) |
> 6 | 118 (39.7) |